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Abstract The arterial pulse at any site is created by an
impulse generated by the left ventricle as it ejects blood into
the aorta, together with multiple impulses travelling in the
opposite direction from reflecting sites in the peripheral
circulation. The compound wave at any site depends on the
pattern of ventricular ejection, the properties of large
arteries, particularly their stiffness (which determines rate of
propagation) and the distance to and impedance mismatch at
reflecting sites. Physicians are familiar with waveform
analysis in the time domain, as in the electrocardiogram
(ECG) where the principal features are explicable on the
basis of atrial depolarisation followed by ventricular depo-
larisation, then repolarisation. Effects of cardiac functional
and structural disease can be inferred from the ECG. It is
more difficult to make similar interpretations from the pulse
waveform and clinicians usually use this only to count heart
rate, extremes of the pressure pulse to express systolic and
diastolic pressure, and (sometimes) time from wave foot to
incisural notch to measure time of systole and diastole. More
information can be gleaned from the shape of the arterial
pressure wave through consideration of the factors which
create it—on stiffening of large arteries with age, effects of
drugs on smallest arteries, and changes in such arterial
properties on left ventricular load and function. Such is a
major challenge to future physicians. It is aided by better and
more accurate methods for measuring flow and diameter as
well as pressure waveforms, and by appropriate use of other
analytic techniques such as analysis of the pulse in the
frequency domain.
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1 Introduction
From my perspective as a clinician and physiologist,
the modern era in arterial haemodynamics began with
the collaboration between Donald McDonald and John
Womersley some 60 years ago, and which introduced
steady-state analysis to the study of pressure gradient and
flow waves in arteries [30]. My mentor Michael Taylor was
the principal offspring of this group, and his contributions
to the study and interpretation of vascular impedance, wave
travel and reflection surpassed those of his mentors
[49, 50]. I first met Taylor in 1962, and saw an approach
which had the prospect of giving new insight into athero-
sclerotic disease, then an even greater scourge than now.
But I had to ‘‘know the ropes’’. This involved a different
process than now. Original works—sometimes first edi-
tions of classic articles—needed be read, instruments made
if they did not exist, and instrumental accuracy scrutinised
in the steady and dynamic state. I read Harvey, Hales,
Wiggers, Gregg and Hamilton, and heard gloomy words on
contemporary authorities in the USA who would not stray
beyond analysis of the pulse in the time domain [43].
Through Harvey’s work and his clash with Riolan from
Paris (best illustrated in the first pages of ‘‘de Circulatone
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Sanguinis’’ [6], I first became aware of real scientific
controversy, and realised that I would likely be embroiled
in the same through the debate that was brewing between
the McDonald camp who would only view the arterial
pulse in the frequency domain, and the Remington group in
the USA who would only view the pulse in the time
domain [43]. Mercifully, both of the groups had been
trained in classical physiology, so that artefacts in pressure
and flow waves were not a source of distraction.
Taylor was fastidious about accuracy—in measure-
ment, reporting and discussion. He was so obsessive that
data recording on FM tape was done with a zero voltage
channel always, so that subtle changes in tape speed
would be apparent and correctable. The first task assigned
me was to dismiss previous assurance on the dynamic
accuracy of the electromagnetic flowmeter, and check this
myself through use of a sinusoidal pump and harmonic
resolver through pumping saline and/or blood through
arterial segments. We managed to show that flow could be
accurately measured if this was axisymmetric, and that
frequency distortion was attributable to the flowmeter’s
electronic filter [33].
My experimental works in second and third years with
Taylor were some of the most productive and satisfying of
my life. In 1963, he had acquired state of the art digital
processing facilities, and had access to Sydney’s first
computer in the School of Physics at Sydney University.
My animal experiments by day were followed by computer
analysis by night, then interpretation through modelling
experiments designed next day. Together we found that the
concept of vascular impedance did work, and did describe
the wave propagation into and wave reflection from various
vascular beds in a host of different animals—studied
deliberately so as to test the theoretic models of different
vascular size, length and branching patterns [30, 49, 50].
Michael Taylor as a pupil of Donald McDonald had
‘‘inherited’’ his views on analysis of the pulse waveforms
in the frequency domain. I worried about this because, as a
simple clinician I was more comfortable with pulse in the
time domain, and needed to explain mechanisms in terms
of the waveforms as well as impedance or other transfer
functions. I managed to win over Taylor, somewhat
grudgingly, if only by convincing him that I could better
identify artefact in the time domain during an experiment,
rather than from results of a transfer function, available
from the computer next day. But I could not convince
Donald McDonald, who when faced with tracings which
showed evidence of strong wave reflection and rereflection
in the arterial tree would not concede such a possibility but
would refer to amplitude and phase of the nth harmonic.
My first paper to show analysis of the pulse waveforms in
both time and frequency domains was reviewed by John
Remington [43] who revealed himself in an encounter with
Bill Milnor who had been asked by Phillip Dow to arbitrate
on behalf of the journal. Remington disliked the paper, and
so did McDonald, yet it was published [34].
Memories such as the above seem relevant in this
journal issue, since the same types of dispute remain, are
fired by human nature and a disinclination to consider
another point of view. The same concerns still exist about
instrumental accuracy, and are now perhaps all the more
important when we utilise non-invasive measurements of
pressure and flow to interpret the effects of ageing and
disease in humans.
2 Clinical practice: link between frequency
and time domain analysis
My brief is to discuss time domain waveform analysis in
clinical medicine. It is important for readers to appreciate
that I entered this field through a frequency domain anal-
ysis path, and have a profound respect for such analysis.
My entry into human clinical haemodynamics was at Johns
Hopkins with Bill Milnor, whose prime clinical interest
was the pulmonary circulation. At the time Donald
McDonald was in Philadelphia, en route to Birmingham,
AL, and Nico Westerhof was in Philadelphia with Bram
Noordergraf. Eugene Braunwald was in Bethesda con-
ducting clinical and experimental cardiovascular studies.
When Chris Mills, Ivor Gabe and John Shillingford visited
Bethesda we were invited to see the new catheter tipped
electromagnetic flowmeter used in the catheterisation lab-
oratory [24]. This opened a new field, but data quality was
often poor, especially for the flow waveforms, while fre-
quency response of the fluid-filled catheter system was
marginal. Huntley Millar then introduced a superior high
fidelity pressure sensor together with electromagnetic flow
sensor mounted below an extended catheter tip; this was
intended to stabilise the catheter in the proximal aorta.
Murgo and colleagues [28, 29] conducted studies of
ascending aortic impedance with this catheter, as did
Merillon, Gourgon and colleagues in France, Nichols in
Gainesville and Yin in Baltimore and Taiwan, and
Yaginuma in Tokyo [30]. We did limited studies and
reverted to collecting data with an electromagnetic sensor
around the ascending aorta of patients at cardiac surgery
[36]. None of the above clinical researchers were happy
with use of the electromagnetic flow catheter sensor, since
different flow patterns were regularly seen, and could be
explained on the basis of jets and secondary flows in the
ascending aorta. Yin’s [60] careful work could only be
completed on a fraction of patients originally studied, and
Yaginuma came to measure pressure and flow in the
proximal descending aorta where flow was more stable.
With time, use of the electromagnetic flow catheter was
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abandoned for measuring ascending aortic impedance,
and such studies are now conducted non-invasively with
Doppler flow from the left ventricular outflow tract and
with pressure determined by carotid tonometry [25], or
synthesised from the radial artery, using arterial tonometry
and a generalised transfer function which corrects for dis-
tortion of the pressure pulse in the upper limb [30, 37].
Achievements in impedance analysis are discussed by
Mitchell in chapter 8 of this supplement. We do have
concerns about the results and interpretations of this work,
since there is little consideration of sources of error in
measurement of flow in the left ventricular outflow tract
and ascending aorta [39, 40]. The same problems of sec-
ondary flows (jets and eddies) that bedevilled invasive
measurement of flow at cardiac catheterisation with the
Mills or Millar pressure/electromagnetic flow catheter are
apparent in the Doppler flow waves as a wide envelope.
The encircling electromagnetic flow probe that we used in
animal and clinical studies appears to have been less
influenced by these flow problems, presumably because
flow was measured in the ascending aorta, and secondary
flows were largely axisymmetric. With this instrument one
invariably got a sharp forward flow wave in systole, with
its peak around 100 ms after the foot (in humans) and no
flow in diastole. With the electromagnetic flow catheter,
considerable difference is seen in published flow waves,
even sequential waves. My assessment of this experience
was largely influenced by my training with Michael Taylor.
There was error in flow recordings that was explicable but
could not be controlled. I all but abandoned flow wave
analysis and sought to analyse the pressure pulse wave
alone, and non-invasively.
My approach to time domain analysis of the pulse was
heavily influenced by the superb work done by Murgo and
colleagues at the Brooke Army Medical Centre in San
Antonio, using Millar pressure/velocity catheters. Murgo
drew attention to the different patterns of pressure wave
that he saw with ageing and disease, and linked these to
different patterns of impedance and to difference in timing
of reflection. It seemed that as in different experimental
animals [30], the pattern of aortic flow waves was similar
in different patients, so one did not need the flow waves or
the impedance patterns to interpret wave reflection and
vascular load, and could get most of the clinical informa-
tion from the pressure waves alone. (This is only partially
true particularly in the presence of systolic LV dysfunction,
as discussed below). But this was the simple practical
compromise we adopted, and sought to make the process
non-invasive through introduction of a Millar sensor on a
hand-held tonometer over the carotid or radial artery
[9, 10]. Most of the early work in my department was
undertaken by the late Ray Kelly with Alberto Avolio,
Chris Hayward and David Gallagher. We followed similar
work in Tokyo by Yaginuma’s pupil Kenji Takazawa [48].
Takazawa’s principal interest was to seek sources of
information and error in the invasively recorded left
ventricular and aortic pressure waveforms, and their rela-
tionship with pressure waves in peripheral arteries such as
the carotid and radial, and the finger volume plethysmo-
graph. His work broadly supported the view that in contrast
to flow waves, the aortic pressure waveform measured by
Millar micromanometer was little influenced by secondary
flows.
Such non-invasive studies were guided by the principles
espoused by Michael Taylor—history, hierarchy, accuracy
and frequency domain analysis. We also belatedly became
aware that we were travelling the same path as nineteenth
century physicists and physicians such as Etienne Marey
[21] and Frederick Mahomed [35] who had introduced
sphygmograms to measure the radial pulse waveform so as
to recognise hypertension, premature arteriosclerosis and
high risk of cardiovascular events [5]. The characteristic
feature of the radial artery waveform in such persons, and
in the aged, apparently well, was a secondary peak in late
systole. Mahomed showed that this corresponded to high
augmentation of the pulse in a central (carotid) artery [35].
Journal articles and textbooks of the late nineteenth and
early twentieth century were liberally illustrated with radial
pulse wave tracings [19], as was the first edition of the
Journal of the American Medical Association.
Kelly’s work [9] with arterial tonometry showed that
this could accurately measure the pressure waveform
features, but not the actual pressure values. This was sup-
ported by work from Yin, Kass and others at Johns
Hopkins [2, 60]. Possibly the most important and certainly
the most controversial work by Kelly and our group in
Sydney was to show that the transmission of the pressure
pulse through the upper limb to the brachial or radial artery
could be characterised by a generalised transfer function
whose properties were little affected by age, vascular dis-
ease or even by vasoactive drugs in normal clinical doses
[8]. This finding was suggested by the simple observation
of cardiac catheterisation (Fig. 1) that there is a fixed
relationship between pressure waves in the aorta and radial
artery before and after sublingual nitroglycerine, such that
change in the aortic pressure wave could be inferred from
the radial [11]. Importance of this finding was that aortic
and left ventricular systolic pressure could fall by as much
as 20 mmHg without this being detected in the upper limb
by conventional recording—even by intra-arterial catheter.
Our views on use of a generalised transfer function pro-
cess for generation of the central aortic pressure waveform
was met with incredulity. Our colleagues (Yin, Kass, Chen
et al.) at Johns Hopkins repeated the process and obtained
substantially similar results [3, Fig. 2]. They, like we, con-
centrated on invasively recorded waveforms from matched
Med Biol Eng Comput (2009) 47:119–129 121
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catheter/tonometer systems so that there was no distraction
from calibration to sphygmomanometer cuff values. This
became a focus for criticism by other clinicians who appar-
ently were unaware of the marked differences between
invasive and non-invasive pressure measurement even when
taken simultaneously [30]. The US FDA was so aware, since
this is the agency’s ‘‘bread and butter’’ through comparison
of different sphygmomanometric systems. The FDA passed
the SphygmoCor device which incorporates the generalised
transfer function for measurement of the central aortic from
the radial pressure waveform under K002742 and K012487.
Use and stability of the generalised transfer function under
different conditions and in models of upper limb arteries
have confirmed our initial claims and even our most vocal
critics now grudgingly agree, though one group has based
their analysis on flawed mathematics as pointed out by
Segers and colleagues [45].
We have favoured use of tonometry on the radial artery
with use of a generalised transfer function to generate the
aortic pressure wave [30]. The principal option is to use
carotid tonometry [2, 25, 46] which provides a waveform
closer in amplitude and contour to the aortic pressure wave
even without use of an appropriate transfer function. We do
this because the radial waveform can be recorded more
accurately, more comfortably, and more safely than the
carotid wave, and because it is hallowed by time and
history [5, 21, 34]. The carotid waveform is an option, and
we use this for recording when there is difficulty or
uncertainty with one or other radial arteries. There is a
predictable relationship between pressure waves in the
aorta, carotid and radial arteries [10, 30, 58].
3 Explanation of aortic pressure and flow waveforms
Relative simple explanations can be given for the patterns
of pressure and flow waves in the ascending aorta—and for
the change in travel to peripheral arteries. The typical flow
waveform [30] is shown in Fig. 3, with rapid rise to early
systolic peak at about 100 ms after the wave foot, and with
a convex pattern to the right down to end systole at around
300 ms, a little backflow and then no flow during diastole.
This pattern does change with heart rate, and with ageing
and ventricular weakening. As heart rate accelerates,
duration of diastole decreases more than systole. The peak
remains at about 100 ms after the wave foot, and the fall to
end systole is more linear. With ageing and ventricular
weakening, and at normal heart rate, the flow during late
systole falls with a concavity rather than a convexity to
the right [27, 30, Fig. 3]. In ventricular failure due to
predominantly systolic dysfunction, ejection duration is
shortened whereas in failure due to diastolic dysfunction,
ejection duration may be lengthened [30]. These changes in
the left ventricular ejection (aortic flow) with age are rel-
atively subtle, and have not been noticed in many analyses
[15, 33]. In contrast, changes in the aortic pressure wave
are striking [11, 26, 28, 30, 38, 46].
The pressure wave in a young adult human (Fig. 3 right)
shows an early peak which occurs about 100 ms after the
wave foot and corresponds to the peak of the flow wave.
After this peak, pressure falls to the incisura which corre-
sponds to aortic valve closure. Between the early peak and
incisura there may be an inflection which corresponds to
the foot of the reflected wave from peripheral sites. This
wave is, however, more prominent throughout diastole and
causes pressure to undulate rather than falling in an
exponential fashion such as one would expect to see if
there were no wave reflection. The features of the aortic
pressure wave—its foot, its initial peak, its late systolic
inflection corresponding to the return of wave reflection,
and the incisura, caused by aortic valve closure—can be
identified from differentials of the pressure wave. These are
so utilised in the SphygmoCor reports [30, 38, Figs. 4, 5].
4 Change in waveforms with age
While changes in the aortic flow wave with age are subtle
[27, 30], as described above, change in the pressure wave
Fig. 1 Pressure waves recorded in the ascending aorta (top) and
brachial artery (bottom) at short time intervals apart during diagnostic
cardiac catheterisation with a Millar micromanometer. Recordings at
left were taken under control conditions. Recordings at right were
taken several minutes after administration of nitroglycerin 0.3 mg
sublingually (after Kelly et al. [10]). In this middle aged man, the
peak of the aortic pressure wave was created by the secondary late
systolic reflected wave whereas in the brachial artery, the initial wave
generated the pressure peak. Reduction in wave reflection by the
arterial vasodilator nitroglycerine reduced amplitude of the secondary
wave. This reduced aortic systolic pressure but not the peak of the
pressure wave in the brachial artery. This same effect has been shown
with calcium channel blocking drugs (CCBs), angiotensin converting
inhibitors (ACEIs), and angiotensin receptor blockers (ARBs) as well
as nitrates, and accounts for the superior effect on blood pressure
lowering as compared to the effect measured directly from pressure
waves or by sphygmomanometric cuff in the upper limb
122 Med Biol Eng Comput (2009) 47:119–129
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are more marked (Fig. 3, right). The initial peak of the
pressure wave remains at about 100 ms after the wave foot,
but pressure continues to rise after this to a peak in late
systole, before falling to the incisura, then decreasing
almost exponentially during diastole. Close inspection of
the pressure wave change shows that the first peak still
corresponds to the peak of flow, but that the beginning of
the second peak corresponds to the late systolic inflection
in the younger subject, and the late systolic peak corre-
sponds to the diastolic pressure surge in the younger
person. As in the younger person, the features can be
detected by differentials of the pressure wave. In the
elderly, the inflection corresponding to return of the
reflection wave, (identified by differentials as a concavity
to left on the original wave) comes so close to the initial
wave peak at around 100 ms that it merges, and no separate
shoulder or inflection may be seen at all [31]. A conse-
quence of the change in the aorta wave shape is that
augmentation of the wave—the rise from the first shoulder
or peak to second peak—increases progressively with age
at least up to 60 years [22, 58]. Rise at older ages is less
steep; this may be due to change in shape of the aortic flow
wave and attributable to decreased left ventricular output at
high pressure in late systole, to reduction in wave reflection
from the lower body as aortic wave velocity increases to
match values of wave velocity in the iliac and femoral
arteries [26], or to the difficulty in identifying the shoulder
from which augmentation is measured [30, 38].
Fig. 2 Pressure waveforms in
the ascending aorta (left) and
radial artery (right) together
(below) with their relationship
described in terms of transfer
functions using two different
techniques (left steady state,
right transients). Data from
Karamanoglu et al. 1993 [8] and
Chen et al. 1996 [2] showed
similar patterns of modulus and
phase. After Chen et al. [2]
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Support for these interpretations comes readily from
clinical observations, as in an elderly patient with slow or
rapid heart rate (Figs. 4, 5), or in a patient with atrial extra
systoles where there is great variation in ejection period
(Fig. 6). Changes in the wave shape at least up to age 60
can only be explained on the basis of wave travel and
strong wave reflection.
5 Change in waveforms with heart failure
Characteristic pressure waveforms in (systolic) heart failure
were described almost a century ago by Thomas Lewis [17],
one of the founders of British cardiology and the first editor
of ‘‘Heart’’. Lewis described a characteristic dicrotic (twice-
beating) pulse; such is typical in patients with severe heart
failure as in intensive care following cardiac surgery, in
cardiogenic shock following myocardial infarction, and in
patients with cardiomyopathy awaiting transplantation
[4, 30, 32]. In such patients, ascending aortic impedance is
similar to that in normal subjects [14, 30] indicating that
vascular properties are similar, that wave reflection is
strong, and the principal cause must be cardiac. The char-
acteristic feature is indeed shortened left ventricular
ejection, such that wave reflection is seen after the aortic
valve shuts as an exaggerated diastolic wave [3, 14, 17, 30,
32]. Further study of this phenomenon suggests, however,
Fig. 3 Schematic flow (left) and pressure (right) waves in the
ascending aorta of a young and old person. In the young person, peak
flow velocity is higher and the late systolic part of the flow waves is
convex to the right. In the older person peak flow velocity is lower
(aortic diameter is greater) and the flow pattern after the peak shows
initial concavity to the right. In the young person amplitude of the
pressure wave is lower, and the peak is seen early in systole. Return of
wave reflection is apparent as an inflection (indicated by an arrow)
shortly before the notch which represents aortic valve closure. In the
older person, amplitude of the pressure wave is greater on account of
a higher initial pressure rise to an early systolic shoulder together with
return of the reflected wave (whose beginning is indicated by an







































Fig. 4 Segment of a
SphygmoCor report in an
87-year-old man, showing (at
top) a series of pressure waves
recorded over 10 s from the
radial artery by applanation
tonometry together with
(immediately below) the
corresponding series of aortic
pressure waves synthesised
from application of the transfer
function process shown in
Fig. 2. Quality control
parameters for the radial
pressure waves are inset
at upper right. The two waves at
bottom are (at left) the
ensemble-averaged radial wave
from data above, calibrated to
values of systolic and diastolic
pressure measured by brachial
cuff, and (at right) the
ensemble-averaged aortic
pressure wave set to the same
mean pressure as determined
for the radial artery. Timing
intervals and central
haemodynamic parameters are
set out below. SP peak systolic
pressure, Dp lowest diastolic
pressure, PP pulse pressure
(Sp-Dp), MP integrated mean
pressure in the radial artery
124 Med Biol Eng Comput (2009) 47:119–129
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that the cardiac phenomenon is a consequence of the vas-
cular phenomenon—a consequence of wave reflection [54].
When ventricular contraction is weakened, the ventricle
acts as a pressure source, with ejection limited by and
terminated prematurely by return of wave reflection. The
simplest demonstration of this mechanism is administration
of a vasodilator agent which reduces wave reflection; this
prolongs ejection duration and increases cardiac output.
Vasodilator therapy is the principal treatment of such
patients—for acute and chronic use, and its benefit is readily
explained on the basis of reducing wave reflection [30].
There is another form of heart failure, typically seen in
older persons, usually women, with longstanding elevation
of arterial pressure and left ventricular hypertrophy. In
these patients, left ventricular contraction paradoxically is
strong; heart failure is due to delayed relaxation and
impaired ventricular filling in diastole, i.e. to diastolic heart
failure [52]. The left ventricle of the patients acts as a flow
source—it ejects strongly against the reflected wave, which
is seen as augmentation of pressure in late systole. Ejection
fraction of the left ventricle is not reduced; ejection dura-
tion may be lengthened [30, 52].
In clinical practice, heart failure is often a mixture of
systolic and of diastolic dysfunction [30, 42]. This develops
gradually with ageing, is attributable to increasing left
ventricular systolic load from arterial degeneration, and is
characterised by decreasing exercise capacity, and breath-
lessness on exertion. The principal feature of this condition
appears to be a consequence of the effects of load on the
ventricle. Ejection duration may be normal or prolonged,
but flow is reduced in late systole, just as it is in the pul-
monary circulation with the development of pulmonary
hypertension [12, 30].
6 Change in waveforms with hypertension
Change in pressure waveforms in hypertension are similar
to those seen with ageing, and are explicable on the same
basis—of increase in arterial stiffness with early return of
wave reflection [30]. These features of the waveform were
first used for identification of hypertension in young sub-
jects by Frederick Mahomed some 135 years ago, well
before introduction of the cuff sphygmomanometer [5, 35].
We now know that hypertension ultimately leads to left





























Fig. 5 Segment of
SphygmoCor report in the same
man as shown in Fig. 4 during
an episode of junctional
tachycardia. As a consequence
of shortened ejection period,
wave reflection causes a boost
to pressure in diastole rather
than during late systole
Fig. 6 Ten-second segment of SphygmoCor report from a 60-year-
old man with extra systoles showing the differences seen in Figs. 4
and 5, but in successive beats
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[16], and that associated left ventricular weakening leads to
reduction in late systolic ventricular ejection, so that the
degree of late systolic augmentation of the pressure wave
progressively decreases [30]. So called ‘‘burnt out hyper-
tension’’ is associated with a lesser degree of pressure
augmentation than previously present.
7 Change in waveforms with vasodilator drugs
Vasodilator drugs are widely used in clinical practice, for
treatment of elevated arterial pressure, for treatment of
cardiac failure (both ‘‘systolic and diastolic’’), and for
management of ischaemic heart disease [30]. The most
effective such drugs and the most effective doses are those
that have predominant effect on muscular arteries, rather
than veins or arterioles, i.e. that do not cause venous
pooling or reduction in peripheral resistance. Benefits are
attributable to reduction in early wave reflection (Fig. 1).
When the left ventricle acts as a flow source as it nor-
mally does [54], contracting powerfully against pressure,
reduction in wave reflection with such drugs is apparent as
decrease in late systolic pressure augmentation. In the aorta
and left ventricle, this is apparent as reduction in systolic
pressure and benefit is obvious. However, when pressure is
measured in the brachial or radial artery, the augmented
wave is in late systole and usually does not constitute the
peak of the wave. Hence systolic pressure fall is underes-
timated [7, 11, 30]. Studies such as REASON [18]
and CAFE [57] have confirmed that the superiority of
vasodilator drugs for reducing cardiovascular events in
hypertension is attributable to greater reduction in central
systolic pressure, i.e. to benefits beyond the brachial artery,
rather than beyond blood pressure.
When the left ventricle acts as a pressure source, with
contraction weak and flow limited by pressure, reduction in
wave reflection by vasodilator drugs has its greatest effect
on flow rather than pressure [30, 54]. This is apparent as an
increase in ejection duration, and in cardiac output [14].
Arterial pressure and the arterial pressure wave may not
appear to change significantly, and the subtle change in
ejection duration may be overlooked.
8 Problems in clinical assessment of the pulse
in the time domain
Accuracy of measurement is the principal problem, and has
been emphasised throughout this article. There are extreme
difficulties in accurate measurement of ascending aortic
flow in all circumstances with invasive and non-invasive
methods. These are a consequence of jets, turbulence,
secondary flow in the inlet to the arterial system where the
pathway narrows at the aortic valve, annulus, dilates at the
sinuses of Valsalva, then narrows again before curving
around to the descending aorta. Our approach has been to
be very careful of flow estimates particularly during early
systole, and of measures which depend on flow patterns
such as impedance. We base our analyses on relative
constancy of the flow pattern under different conditions,
but with appreciation of how flow contour can be altered by
reduction of ventricular contractility when output during
late systole becomes highly dependent on pressure.
Analysis of the pressure pulse depends on the accuracy of
the recording method. Problems of low frequency response
of fluid-filled catheter systems are well known [30], but are
often overlooked by clinicians, particularly those undertak-
ing cardiac catheterisation procedures. Accurate tonometry
requires careful applanation (flattening) of the surface of the
artery [2, 9, 30]. This is harder to achieve consistently in the
carotid than radial site on account of the artery being further
from the skin and poorly supported laterally, with tendency
of the whole artery to move, kink, or flip [15].
A particular problem arises with measurement of pres-
sure augmentation or augmentation index, since this
requires identification of the first peak or shoulder which
corresponds to the peak of flow in the artery [10, 26]. (This
shoulder needs be distinguished from the subsequent
inflection which corresponds to the foot of the reflected
wave [41]). Both of these may be influenced by a Venturi
effect in the ascending aorta, which can result in the point
being measured around 4 mmHg lower in the aorta than in
the left ventricle [41, 48]. Inflections on the wave such as
this shoulder, but also the foot and incisura are composed
of high frequency components of the waves, and depend on
capacity to adequately record frequencies up to at least
12 Hz [3], and not to filter these in instruments or through
use of an inappropriate transfer function [45].
Problems in identification of a shoulder on the central
pressure wave can explain many anomalies in present
literature [41, 46, 47].
Use of transfer functions are better accepted now than in
the past [37], and are apparent in description of vascular
impedance by Mitchell in Chap. 8 of this supplement.
However, use of a generalised transfer function for gen-
erating aortic pressure waveforms from radial waveforms
has taken longer [38, 45]. It is possible to use these inap-
propriately when phase is not properly expressed and/or
when harmonics are compared rather than absolute
frequencies [45].
9 Apparent anomalies
Research would lose its interest if it did not throw up new
challenges. One of these challenges is that augmentation
126 Med Biol Eng Comput (2009) 47:119–129
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index (AIx) of the pressure wave in the aorta, radial and
carotid arteries does not increase progressively with age,
flattening off over age 60 [10, 22, 58], and does not over
60 years correlate with cardiovascular events [51] whereas,
aortic PWV (an accepted measure of stiffness) does
increase progressively with age [15, 22, 30] and does
correlate with events at all ages [15]. Related to this is that
in diabetic subjects under age 60, with known greater risk
of cardiovascular events, and with greater aortic PWV
often have lower AIx than normal subjects [13]. Another
related possibility is that persons with abdominal adiposity
whether they have diabetes or not often have lower AIx
than normal subjects of the same age [20]. Contrary results
have been reported [59].
The probable explanation is intriguing, and exposes a
possible wider value of pulse wave analysis. AIx in the
aorta cannot exceed 50%. The reflected wave cannot
exceed the amplitude of the incident wave. Values over
50% are suspect. But the incident wave has similar pattern
to the aortic flow wave which generates it. Declining LV
function with age causes a change in shape of the aortic
flow wave such that ejection in later systole is reduced.
This will affect the amplitude of the reflected wave and of
the resultant compound wave. The phenomenon has been
described earlier in this article. The plateau or decline in
AIx with age is partly attributable to development of car-
diac weakening and incipient heart failure. It is also partly
attributable to reduction in aortic wave reflection as pro-
posed by Mitchell [26]. Separation of compound waves
into incident and reflected waves was first described by
Westerhof et al. in 1972 [55]. The same group has shown
early return of wave reflection as the cause of increase in
augmentation with age [53].
Most studies of diabetic subjects show higher values
of aortic AIx than control [1, 56] but some show lower
values [13]. The explanation of diabetes follows from this.
Diabetic cardiomyopathy is well known as a cause of
premature left ventricular weakening due to impaired fatty
acid metabolism in the heart with generation of toxic
metabolites [23, 44]. Lower AIx in some diabetics may be
a manifestation of this, and may be a reason for introducing
early therapy for cardiac failure. Recent studies [23] have
shown a similar problem in persons with abdominal
obesity—with evidence of abnormal lipid accumulation in
the heart.
Previous commentary on this issue has focussed on
lower than anticipated AIx being a manifestation of altered
wave reflection [20, 26] or as a fault of the technique. It
may be neither, but something even more important—
a manifestation of another problem (incipient left ventri-
cular failure) which may warrant early or intensified
treatment.
10 Summary
Time domain analysis of the pulse in clinical medicine
stretches back to the times of Marey, Mahomed and
Mackenzie when diagnoses were made, therapy planned
and prognosis assessed on the basis of the radial pulse
waveform. Modern advances follow recognition of limi-
tations and shortcomings of brachial cuff blood pressure
analysis, and depend on better instruments for recording
arterial pressure and flow pulses, better understanding of
arterial haemodynamics and ventricular/vascular interac-
tion, and greater appreciation of artefact. Modern analysis
of the pulse in the time domain supports the conventional
historical views, and those that emerge from other analy-
ses, and emphasise the importance of arterial stiffening
with age, and of wave reflection, their effects on the heart
and their modification with therapy.
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